| Net Cash Provided by (Used in) Operating Activities |
$277,886,000 |
USD |
4.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$45,677,000 |
USD |
-104% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,035,470,000 |
USD |
-8.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
170,487,574 |
shares |
0.33% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,802,458,000 |
USD |
-346% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,188,139,000 |
USD |
-20% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$434,683,000 |
USD |
-28% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$13,353,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$579,701,000 |
USD |
-3.6% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$138,206,000 |
USD |
55% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,564,838,000 |
USD |
30% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$22,453,000 |
USD |
-225% |
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$2,752,000 |
USD |
-41% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$2,111,316,000 |
USD |
4% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$49,440,000 |
USD |
-4.3% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$566,348,000 |
USD |
-5.8% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$1,746,181,000 |
USD |
116% |
Q2 2024 |
Q2 2024 |